FactaeThe Factual News

Belgian pharma group UCB acquires Candid Therapeutics

Belgian pharmaceutical group UCB announces the acquisition of Candid Therapeutics for an undisclosed amount.

Published 19sem1 sourceNotableupdated 5sem
Lire en français
≈ 17s

The fact

This operation strengthens the laboratory's presence in immunotherapy and innovative treatments.

Integration is expected to begin before the end of 2026.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Belgique · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on May 4, 2026
← Back to home
Discover

Read more

All economie →
economie

The Fed raises interest rates by a quarter point and hints at another hike by the end of 2024

5h · 1 sourceeconomie

SK Hynix may lease part of Intel's Ohio chip plant

15h · 1 sourceeconomie

Ursula von der Leyen defends EU's 'industrial independence'

16h · 1 sourceeconomie

AI brings Bernie Sanders and Steve Bannon together against tech giants

16h · 1 sourceeconomie

France criticized for fiscal laxity amid European debt concerns

7h · 1 sourceeconomie

European telecom operators oppose Huawei's exclusion

13h · 1 source